Performance analysis of MedTech Acquisition (MTAC)
Annual Return
Over the past 3 years, MTAC has had an average annual return of +8.52%, outperforming the benchmark SPY, which returned +4.79% annual.
Over the past 5 years, MTAC has had an average annual return of +6.89%, outperforming the benchmark SPY, which returned +4.15% annual.
Since Feb 8, 2021, MTAC has had an average annual return of +3.04%, underperforming the benchmark SPY, which returned +7.02% annual.
| 2023 | 2022 | 2021 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +13.06% | +1.51% | -6.08% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | +0.60% | +0.30% | +0.79% | -0.10% | +2.16% | +0.68% | -6.97% | +16.30% | +13.06% | ||||
| 2022 | -0.20% | +1.01% | -1.61% | +0.30% | -0.10% | +0.25% | +0.36% | +0.40% | +0.10% | +0.71% | +0.60% | -0.30% | +1.51% |
| 2021 | -2.28% | -6.03% | +1.24% | -0.82% | +0% | +0.10% | +1.24% | +1.02% | +0.20% | +0.20% | -0.90% | -6.08% |
Drawdown analysis of MedTech Acquisition (MTAC)
The maximum drawdown for the MTAC was -13.92%, occurring on Mar 7, 2022. Recovery took 359 trading sessions.
Since Feb 8, 2021 MTAC has experienced the following drawdowns:
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -13.92% | Feb 19, 2021 | 263 | Mar 7, 2022 | 359 | Aug 10, 2023 | 622 |
| -1.90% | Feb 8, 2021 | 4 | Feb 12, 2021 | 1 | Feb 16, 2021 | 5 |